Screener
Capricor Therapeutics CAPR Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$40.73M-57.2% | -$33.94M-39.2% | -$30.17M-324% | -$24.57M-95.7% | -$25.91M-136% | ||
| $561.85K+15.5% | $534.67K+31.9% | $502.59K+33.8% | $494.73K+37.0% | $486.28K+36.2% | ||
| $6.06M+66.2% | $5.92M+8.0% | $3.84M+67.3% | $4M+94.9% | $3.65M+69.4% | ||
| -$31.49M-56.5% | -$29.25M-355% | -$23.57M-59.3% | -$19.69M-69.1% | -$20.12M-63.7% | ||
| $4.06M+1,312% | $5.12M+472% | $1.66M+241% | $55.84K+511% | $287.74K+377% | ||
| -$48.76M-435% | -$154.64M-747% | $43.09M+135% | $15.95M+696% | $14.55M-1.0% | ||
| -$4.24M-21,770% | $1.47M+2,821% | $248.82M+207% | $6.95K-100.0% | $19.58K-99.1% | ||
| -$84.49M— | -$182.43M-1,142% | $268.34M+570% | —— | —— | ||
| -$35.55M-74.2% | -$34.38M-369% | -$25.23M-65.1% | -$19.74M-69.5% | -$20.41M-65.3% |
FAQ
- How much cash does Capricor Therapeutics generate?
- Capricor Therapeutics (CAPR) generated -$104.0M in operating cash flow over the trailing twelve months.
- What is Capricor Therapeutics's free cash flow?
- After $10.9M of capital expenditures, Capricor Therapeutics's free cash flow was -$114.9M over the trailing twelve months, down 110.1% year over year.
- Where does Capricor Therapeutics's cash flow data come from?
- Every line is extracted from Capricor Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.